Moving Forward: Investigational C Diff Vaccine, Therapeutics Headline Conference
November 4th 2021Highlights from the morning session of the C Diff Foundation Conference included data about Pfizer's investigational vaccine, insights about Seres Therapeutics microbiome therapeutic, and a look at CDI incidence rates around COVID-19.
The Role of Antimicrobial Stewardship in Deterring C Difficile
November 4th 2021The development of these programs are being looked at for private practices in the community settings to try to create better prescribing practices and avoid the potential progression to health care associated infections.
ACIP Updates Recommended Vaccines and Immunization Schedules after 2-Day Meeting
November 3rd 2021The CDC’s Advisory Committee on Immunization Practices voted to recommend hepatitis B, orthopoxviruses, and Ebola vaccines to certain populations, as well as approving 2022 immunization schedules for children, adolescents, and adults.